Endpoints News 生物医药· Ryan Cross·· 2026-10-20AI 评分28
Astellas 与波士顿“迷你蛋白”初创公司达成合作
Exclusive: Astellas partners with Boston ‘miniproteins’ startup
AI 导读
Astellas 与一家总部位于波士顿的“迷你蛋白”初创公司达成合作。Astellas 项目负责人 Chris Bahl 认为,AI 有助于研发能执行传统抗体等较大蛋白质难以完成任务的微小蛋白质。该消息发布时原文后续内容需付费订阅方可阅读。
正文
Chris Bahl believes AI can help make tiny proteins capable of doing things that bigger and more traditional proteins like antibodies struggle to do. And …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news